Sartorius Aktiengesellschaft (SSSGY)
USD 39.0
(0.0%)
USD 39.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 5.02 Billion EUR | 152.91% |
| 2022 | 1.98 Billion EUR | 14.28% |
| 2021 | 1.73 Billion EUR | -8.13% |
| 2020 | 1.89 Billion EUR | 115.56% |
| 2019 | 877.57 Million EUR | -1.91% |
| 2018 | 894.64 Million EUR | 0.82% |
| 2017 | 887.39 Million EUR | 96.35% |
| 2016 | 451.94 Million EUR | 23.47% |
| 2015 | 366.04 Million EUR | -3.33% |
| 2014 | 378.66 Million EUR | 2.67% |
| 2013 | 368.82 Million EUR | 49.55% |
| 2012 | 246.63 Million EUR | -9.07% |
| 2011 | 271.24 Million EUR | 31.28% |
| 2010 | 206.6 Million EUR | -20.97% |
| 2009 | 261.41 Million EUR | 0.0% |
| 2008 | - EUR | -100.0% |
| 2007 | 13.62 Million EUR | -52.17% |
| 2006 | 28.49 Million EUR | -33.42% |
| 2005 | 42.79 Million EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 4.86 Billion EUR | -3.27% |
| 2024 Q2 | 4.31 Billion EUR | -9.05% |
| 2024 Q3 | 4.29 Billion EUR | -0.61% |
| 2023 Q3 | 5.03 Billion EUR | 120.82% |
| 2023 Q2 | 2.28 Billion EUR | 1.57% |
| 2023 Q1 | 2.24 Billion EUR | 13.09% |
| 2023 Q4 | 5.02 Billion EUR | -0.29% |
| 2023 FY | 5.02 Billion EUR | 152.91% |
| 2022 Q3 | 1.67 Billion EUR | -1.77% |
| 2022 FY | 1.98 Billion EUR | 14.28% |
| 2022 Q2 | 1.7 Billion EUR | -1.53% |
| 2022 Q4 | 1.98 Billion EUR | 18.28% |
| 2022 Q1 | 1.73 Billion EUR | -0.11% |
| 2021 Q3 | 1.76 Billion EUR | 0.69% |
| 2021 Q2 | 1.75 Billion EUR | -7.5% |
| 2021 Q1 | 1.89 Billion EUR | 0.11% |
| 2021 Q4 | 1.73 Billion EUR | -1.46% |
| 2021 FY | 1.73 Billion EUR | -8.13% |
| 2020 Q4 | 1.89 Billion EUR | -6.38% |
| 2020 Q1 | 905.2 Million EUR | 3.15% |
| 2020 Q2 | 1.67 Billion EUR | 84.54% |
| 2020 Q3 | 2.02 Billion EUR | 20.96% |
| 2020 FY | 1.89 Billion EUR | 115.56% |
| 2019 FY | 877.57 Million EUR | -1.91% |
| 2019 Q4 | 877.57 Million EUR | -4.31% |
| 2019 Q3 | 917.1 Million EUR | -5.31% |
| 2019 Q2 | 968.5 Million EUR | 6.03% |
| 2019 Q1 | 913.4 Million EUR | 2.1% |
| 2018 FY | 894.64 Million EUR | 0.82% |
| 2018 Q2 | 910.8 Million EUR | 1.12% |
| 2018 Q3 | 913.7 Million EUR | 0.32% |
| 2018 Q4 | 894.64 Million EUR | -2.09% |
| 2018 Q1 | 900.7 Million EUR | 1.5% |
| 2017 Q2 | 924.5 Million EUR | 71.33% |
| 2017 Q4 | 887.39 Million EUR | -3.97% |
| 2017 FY | 887.39 Million EUR | 96.35% |
| 2017 Q1 | 539.6 Million EUR | 19.39% |
| 2017 Q3 | 924.1 Million EUR | -0.04% |
| 2016 Q1 | 395.6 Million EUR | 8.07% |
| 2016 FY | 451.94 Million EUR | 23.47% |
| 2016 Q4 | 451.94 Million EUR | -15.13% |
| 2016 Q3 | 532.5 Million EUR | 2.42% |
| 2016 Q2 | 519.9 Million EUR | 31.42% |
| 2015 Q1 | 332.8 Million EUR | -12.11% |
| 2015 FY | 366.04 Million EUR | -3.33% |
| 2015 Q4 | 366.04 Million EUR | 12.21% |
| 2015 Q3 | 326.2 Million EUR | -4.68% |
| 2015 Q2 | 342.2 Million EUR | 2.82% |
| 2014 Q2 | 377.8 Million EUR | 2.52% |
| 2014 Q1 | 368.5 Million EUR | -0.09% |
| 2014 FY | 378.66 Million EUR | 2.67% |
| 2014 Q3 | 375.3 Million EUR | -0.66% |
| 2014 Q4 | 378.66 Million EUR | 0.9% |
| 2013 Q1 | 235.2 Million EUR | -4.63% |
| 2013 Q4 | 368.82 Million EUR | 9.48% |
| 2013 FY | 368.82 Million EUR | 49.55% |
| 2013 Q3 | 336.9 Million EUR | 37.9% |
| 2013 Q2 | 244.3 Million EUR | 3.87% |
| 2012 Q4 | 246.63 Million EUR | -19.08% |
| 2012 FY | 246.63 Million EUR | -9.07% |
| 2012 Q1 | 307.9 Million EUR | 13.51% |
| 2012 Q2 | 318 Million EUR | 3.28% |
| 2012 Q3 | 304.8 Million EUR | -4.15% |
| 2011 Q3 | 205.1 Million EUR | -6.18% |
| 2011 Q2 | 218.6 Million EUR | 5.91% |
| 2011 Q1 | 206.4 Million EUR | -0.1% |
| 2011 FY | 271.24 Million EUR | 31.28% |
| 2011 Q4 | 271.24 Million EUR | 32.25% |
| 2010 Q3 | 234.5 Million EUR | -7.97% |
| 2010 Q1 | 275.5 Million EUR | 5.39% |
| 2010 Q4 | 206.6 Million EUR | -11.89% |
| 2010 Q2 | 254.8 Million EUR | -7.51% |
| 2010 FY | 206.6 Million EUR | -20.97% |
| 2009 FY | 261.41 Million EUR | 0.0% |
| 2009 Q4 | 261.41 Million EUR | 0.0% |
| 2008 FY | - EUR | -100.0% |
| 2007 FY | 13.62 Million EUR | -52.17% |
| 2006 FY | 28.49 Million EUR | -33.42% |
| 2005 FY | 42.79 Million EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | -612.244% |
| Ansell Limited | 706.6 Million USD | -610.911% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -22313.876% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -803628.0% |
| ConvaTec Group Plc | 1.22 Billion USD | -310.009% |
| ConvaTec Group Plc | 1.22 Billion USD | -309.43% |
| Encision Inc. | 67.33 Thousand USD | -7459951.087% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -1312025.004% |
| LifePoint, Inc. | 151.73 Thousand USD | -3310496.175% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -102124.257% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -816696.748% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -2791195.989% |
| SmileDirectClub, Inc. | 849.37 Million USD | -491.409% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | -2283.197% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -10359569.203% |
| Vasamed, Inc. | 18.95 Thousand USD | -26508079.42% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -27199921.659% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -1286457.646% |